Skip to main content
Top
Published in: Diabetologia 7/2008

01-07-2008 | Article

Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery

Authors: S. Salinari, A. Bertuzzi, A. Iaconelli, M. Manco, G. Mingrone

Published in: Diabetologia | Issue 7/2008

Login to get access

Abstract

Aims/hypothesis

We have previously demonstrated that type 2 diabetes resolves after bariatric surgery. To study the role of NEFA in the prompt normalisation of beta cell glucose sensitivity, insulin secretion and beta cell glucose and lipid metabolism were investigated by a model of nutrient-stimulated insulin secretion using a multiple-meal test.

Methods

Hourly glucose, C-peptide and NEFA were measured in nine morbidly obese, type 2 diabetic patients before and 1 week after bariatric surgery and in six matched healthy volunteers over 24 h. A mathematical model of glucose–NEFA comodulation of insulin secretion rate (ISR) was used to compute ISR and β-oxidation. Insulin sensitivity was measured by an OGTT minimal model.

Results

Beta cell sensitivity to glucose and NEFA was doubled after surgery, while the 24 h insulin secretion decreased from 277.1 ± 144.4 to 198.0 ± 107.6 nmol/m2 (p < 0.02). Insulin sensitivity was restored. The β-oxidation rate of beta cells was completely normalised (from 0.032 ± 0.012 × 10−12 to 0.103 ± 0.031 × 10−12 mmol/min per cell, p < 0.005). The best predictor of beta cell function improvement was the duration of diabetes.

Conclusions/interpretation

Bariatric surgery in type 2 diabetes restores β-oxidation in beta cells, doubles glucose–NEFA sensitivity and reverses diabetes. It is likely that ISR is reduced to match insulin-sensitivity normalisation, in spite of no significant reduction in NEFA levels. We hypothesise that insulin sensitivity normalisation might appear as a consequence of nutrient exclusion from proximal intestinal transit, and that secondarily the need for insulin secretion diminishes. The insulin sensitivity increase is much higher than usually obtained by insulin-sensitising agents and is independent of weight changes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rebuffe-Scrive M, Anderson B, Olbe L, Bjorntorp P (1990) Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 39:1021–1025PubMedCrossRef Rebuffe-Scrive M, Anderson B, Olbe L, Bjorntorp P (1990) Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 39:1021–1025PubMedCrossRef
2.
go back to reference Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMedCrossRef Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMedCrossRef
3.
go back to reference Cusi K, DeFronzo RA (2001) Non-insulin dependent diabetes mellitus. In: Jefferson LS, Cherrington AD (eds) The endocrine pancreas and regulation of metabolism, handbook of physiology. Oxford University Press, New York, pp 1115–1168 Cusi K, DeFronzo RA (2001) Non-insulin dependent diabetes mellitus. In: Jefferson LS, Cherrington AD (eds) The endocrine pancreas and regulation of metabolism, handbook of physiology. Oxford University Press, New York, pp 1115–1168
4.
go back to reference Kelley D, Mandarino L (2000) Fuel selection in human skeletal muscle in insulin resistance. A reexamination. Diabetes 49:677–683PubMedCrossRef Kelley D, Mandarino L (2000) Fuel selection in human skeletal muscle in insulin resistance. A reexamination. Diabetes 49:677–683PubMedCrossRef
5.
go back to reference Magnan C, Cruciani C, Clement L et al (2001) Glucose-induced insulin hypersecretion in lipid-infused healthy subjects is associated with a decrease in plasma norepinephrine concentration and urinary excretion. J Clin Endocrinol Metab 86:4901–4907PubMedCrossRef Magnan C, Cruciani C, Clement L et al (2001) Glucose-induced insulin hypersecretion in lipid-infused healthy subjects is associated with a decrease in plasma norepinephrine concentration and urinary excretion. J Clin Endocrinol Metab 86:4901–4907PubMedCrossRef
6.
go back to reference Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44:863–869PubMedCrossRef Unger RH (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44:863–869PubMedCrossRef
7.
go back to reference Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA (1992) The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575–1586PubMedCrossRef Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo RA (1992) The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 41:1575–1586PubMedCrossRef
8.
go back to reference Lillioja S, Mott D, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329:1988–1992PubMedCrossRef Lillioja S, Mott D, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329:1988–1992PubMedCrossRef
9.
go back to reference Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M (1997) Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. J Clin Invest 100:86–96 Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M (1997) Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. J Clin Invest 100:86–96
10.
go back to reference Nolan CJ, Madiraju MSR, Delghingaro-Augusto V, Peyot M-L, Prentki M (2006) Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 55:S16–S23PubMedCrossRef Nolan CJ, Madiraju MSR, Delghingaro-Augusto V, Peyot M-L, Prentki M (2006) Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 55:S16–S23PubMedCrossRef
11.
go back to reference Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in non-diabetic subjects genetically predisposed to type 2 diabetes. Diabetes 52:2461–2474PubMedCrossRef Kashyap S, Belfort R, Gastaldelli A et al (2003) A sustained increase in plasma free fatty acids impairs insulin secretion in non-diabetic subjects genetically predisposed to type 2 diabetes. Diabetes 52:2461–2474PubMedCrossRef
12.
go back to reference Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E (2007) Effects on insulin secretion and action of a 48-hour reduction of plasma FFA with acipimox in non-diabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab 292:E1775–E1781PubMedCrossRef Cusi K, Kashyap S, Gastaldelli A, Bajaj M, Cersosimo E (2007) Effects on insulin secretion and action of a 48-hour reduction of plasma FFA with acipimox in non-diabetic subjects genetically predisposed to type 2 diabetes. Am J Physiol Endocrinol Metab 292:E1775–E1781PubMedCrossRef
13.
go back to reference Mingrone G, Manco M, Granato L et al (2005) Leptin pulsatility in formerly obese women. FASEB J 19:1380–1382PubMed Mingrone G, Manco M, Granato L et al (2005) Leptin pulsatility in formerly obese women. FASEB J 19:1380–1382PubMed
14.
go back to reference Vettor R, Mingrone G, Manco M et al (2003) Reduced expression of uncoupling proteins-2 and -3 in adipose tissue in post-obese patients submitted to biliopancreatic diversion. Eur J Endocrinol 148:543–550PubMedCrossRef Vettor R, Mingrone G, Manco M et al (2003) Reduced expression of uncoupling proteins-2 and -3 in adipose tissue in post-obese patients submitted to biliopancreatic diversion. Eur J Endocrinol 148:543–550PubMedCrossRef
15.
go back to reference Greco AV, Mingrone G, Vettor R et al (2002) Lowering of circulating free-fatty acids levels and reduced expression of leptin in white adipose tissue in postobesity status. J Investig Med 50:207–213PubMedCrossRef Greco AV, Mingrone G, Vettor R et al (2002) Lowering of circulating free-fatty acids levels and reduced expression of leptin in white adipose tissue in postobesity status. J Investig Med 50:207–213PubMedCrossRef
16.
go back to reference Mingrone G, De Gaetano A, Greco AV et al (1997) Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 40:599–605PubMedCrossRef Mingrone G, De Gaetano A, Greco AV et al (1997) Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 40:599–605PubMedCrossRef
17.
go back to reference Camastra S, Manco M, Mari A et al (2007) Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care 30:1002–1004PubMedCrossRef Camastra S, Manco M, Mari A et al (2007) Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care 30:1002–1004PubMedCrossRef
18.
go back to reference Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025–2031PubMedCrossRef Guidone C, Manco M, Valera-Mora E et al (2006) Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 55:2025–2031PubMedCrossRef
19.
go back to reference Salinari S, Bertuzzi A, Manco M, Mingrone G (2007) NEFA-glucose comodulation model of beta-cell insulin secretion in 24-h multiple-meal test. Am J Physiol Endocrinol Metab 292:E1890–E1898PubMedCrossRef Salinari S, Bertuzzi A, Manco M, Mingrone G (2007) NEFA-glucose comodulation model of beta-cell insulin secretion in 24-h multiple-meal test. Am J Physiol Endocrinol Metab 292:E1890–E1898PubMedCrossRef
20.
go back to reference Mari A, Camastra S, Toschi E et al (2001) A model for glucose control of insulin secretion in 24 h of free living. Diabetes 50(Suppl 1):S164–S168PubMedCrossRef Mari A, Camastra S, Toschi E et al (2001) A model for glucose control of insulin secretion in 24 h of free living. Diabetes 50(Suppl 1):S164–S168PubMedCrossRef
21.
go back to reference Mari A, Schimtz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed Mari A, Schimtz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed
22.
go back to reference Prentki M, Corkey BE (1996) Are the beta-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273–283PubMedCrossRef Prentki M, Corkey BE (1996) Are the beta-cell signaling molecules malonyl-CoA and cytosolic long-chain acyl-CoA implicated in multiple tissue defects of obesity and NIDDM? Diabetes 45:273–283PubMedCrossRef
23.
go back to reference Nolan CJ, Leahy JL, Delghingaro-Augusto V et al (2006) Beta-cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Diabetologia 49:2120–2130PubMedCrossRef Nolan CJ, Leahy JL, Delghingaro-Augusto V et al (2006) Beta-cell compensation for insulin resistance in Zucker fatty rats: increased lipolysis and fatty acid signalling. Diabetologia 49:2120–2130PubMedCrossRef
24.
go back to reference Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Diabetes Care 26:S5–S20 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Diabetes Care 26:S5–S20
25.
go back to reference Dalla Man C, Yarasheski KE, Caumo A et al (2005) Insulin sensitivity by oral glucose minimal models: validation against clamp. Am J Physiol Endocrinol Metab 289:E954–E959PubMedCrossRef Dalla Man C, Yarasheski KE, Caumo A et al (2005) Insulin sensitivity by oral glucose minimal models: validation against clamp. Am J Physiol Endocrinol Metab 289:E954–E959PubMedCrossRef
26.
go back to reference Siri WE (1961) Body composition from fluid spaces and density: analysis of methods. In: Brozek J, Henschel A (eds) Techniques of measuring body composition. National Academy of Sciences, National Research Council, Washington, DC, pp 107–141 Siri WE (1961) Body composition from fluid spaces and density: analysis of methods. In: Brozek J, Henschel A (eds) Techniques of measuring body composition. National Academy of Sciences, National Research Council, Washington, DC, pp 107–141
27.
go back to reference Culebras JM, Moore FD (1977) Total body water and the exchangeable hydrogen. I. Theoretical calculation of nonaqueous exchangeable hydrogen in man. Am J Physiol Regul Integr Comp Physiol 232:R54–R59 Culebras JM, Moore FD (1977) Total body water and the exchangeable hydrogen. I. Theoretical calculation of nonaqueous exchangeable hydrogen in man. Am J Physiol Regul Integr Comp Physiol 232:R54–R59
28.
go back to reference Sheng HP, Huggins RA (1979) A review of body composition studies with emphasis on total body water and fat. Am J Clin Nutr 32:630–647PubMed Sheng HP, Huggins RA (1979) A review of body composition studies with emphasis on total body water and fat. Am J Clin Nutr 32:630–647PubMed
29.
go back to reference Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V (1979) Bilio-pancreatic bypass for obesity. II. Initial experience in man. Br J Surg 66:618–620PubMedCrossRef Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Bachi V (1979) Bilio-pancreatic bypass for obesity. II. Initial experience in man. Br J Surg 66:618–620PubMedCrossRef
30.
go back to reference Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Frank B (1986) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and in type I diabetic patients. J Clin Invest 77:98–105PubMedCrossRef Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Frank B (1986) Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and in type I diabetic patients. J Clin Invest 77:98–105PubMedCrossRef
31.
go back to reference van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMedCrossRef van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMedCrossRef
32.
go back to reference Olofsson CS, Göpel SO, Barg S et al (2002) Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic beta-cells. Pflügers Archiv 444:43–51PubMedCrossRef Olofsson CS, Göpel SO, Barg S et al (2002) Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic beta-cells. Pflügers Archiv 444:43–51PubMedCrossRef
33.
go back to reference Pories WJ, Swanson M, MacDonald KG et al (1995) Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 222:339–352PubMedCrossRef Pories WJ, Swanson M, MacDonald KG et al (1995) Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 222:339–352PubMedCrossRef
34.
go back to reference Bergman RN (1989) Toward physiological understanding of glucose tolerance. Minimal-model approach. Lilly lecture. Diabetes 38:1512–1527PubMedCrossRef Bergman RN (1989) Toward physiological understanding of glucose tolerance. Minimal-model approach. Lilly lecture. Diabetes 38:1512–1527PubMedCrossRef
35.
go back to reference Stumvoll M, Tataranni A, Stefan N, Vozarova B, Bogardus C (2003) Glucose allostasis. Diabetes 52:903–909PubMedCrossRef Stumvoll M, Tataranni A, Stefan N, Vozarova B, Bogardus C (2003) Glucose allostasis. Diabetes 52:903–909PubMedCrossRef
36.
go back to reference Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 44:929–945PubMedCrossRef Pratley RE, Weyer C (2001) The role of impaired early insulin secretion in the pathogenesis of type II diabetes mellitus. Diabetologia 44:929–945PubMedCrossRef
37.
go back to reference Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMedCrossRef Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794PubMedCrossRef
38.
go back to reference Gerich JE (2003) Contributions of insulin resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78:447–456PubMedCrossRef Gerich JE (2003) Contributions of insulin resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 78:447–456PubMedCrossRef
39.
go back to reference Elbein SC, Hasstedt SJ, Wegner K, Kahn SE (1999) Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 84:1398–1403PubMedCrossRef Elbein SC, Hasstedt SJ, Wegner K, Kahn SE (1999) Heritability of pancreatic beta-cell function among nondiabetic members of Caucasian familial type 2 diabetic kindreds. J Clin Endocrinol Metab 84:1398–1403PubMedCrossRef
40.
go back to reference Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166–1173PubMedCrossRef Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G (1997) Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166–1173PubMedCrossRef
41.
go back to reference Ferrannini E, Gastaldelli A, Miyazaki Y et al (2003) Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211–1219PubMedCrossRef Ferrannini E, Gastaldelli A, Miyazaki Y et al (2003) Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 46:1211–1219PubMedCrossRef
42.
go back to reference Haffner S, Howard G, Mayer E et al (1997) Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 47:63–69CrossRef Haffner S, Howard G, Mayer E et al (1997) Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 47:63–69CrossRef
43.
go back to reference UK Prospective Diabetes Study Group (1995) Prospective diabetes study 16: overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258CrossRef UK Prospective Diabetes Study Group (1995) Prospective diabetes study 16: overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes 44:1249–1258CrossRef
44.
go back to reference Schauer PR, Burguera B, Ikramuddin S et al (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484PubMed Schauer PR, Burguera B, Ikramuddin S et al (2003) Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467–484PubMed
45.
go back to reference Frigerio F, Chaffard G, Berwaer M, Maechler P (2006) The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate. Biochem Pharmacol 72:965–973PubMedCrossRef Frigerio F, Chaffard G, Berwaer M, Maechler P (2006) The antiepileptic drug topiramate preserves metabolism-secretion coupling in insulin secreting cells chronically exposed to the fatty acid oleate. Biochem Pharmacol 72:965–973PubMedCrossRef
46.
go back to reference Lee Y, Hirose H, Zhou Y-T, Esser V, McGarry JD, Unger RH (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46:408–413PubMedCrossRef Lee Y, Hirose H, Zhou Y-T, Esser V, McGarry JD, Unger RH (1997) Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes 46:408–413PubMedCrossRef
47.
go back to reference Polonsky KS, Given BD, Hirsch LJ et al (1988) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231–1239PubMed Polonsky KS, Given BD, Hirsch LJ et al (1988) Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med 318:1231–1239PubMed
48.
go back to reference Calles-Escandon J, Jaspan J, Robbins DC (1989) Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity. Diabetes Care 12:709–714PubMedCrossRef Calles-Escandon J, Jaspan J, Robbins DC (1989) Postprandial oscillatory patterns of blood glucose and insulin in NIDDM. Abnormal diurnal insulin secretion patterns and glucose homeostasis independent of obesity. Diabetes Care 12:709–714PubMedCrossRef
49.
go back to reference Gumbiner B, van Cauter E, Beltz WF et al (1996) Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effect of weight reduction. J Clin Endocrinol Metab 81:2061–2068PubMedCrossRef Gumbiner B, van Cauter E, Beltz WF et al (1996) Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effect of weight reduction. J Clin Endocrinol Metab 81:2061–2068PubMedCrossRef
50.
go back to reference Toffolo G, Breda E, Cavaghan MK, Ehrmann DA, Polonsky KS, Cobelli C (2001) Quantitative indexes of beta-cell function during graded up and down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab 280:E2–E10PubMed Toffolo G, Breda E, Cavaghan MK, Ehrmann DA, Polonsky KS, Cobelli C (2001) Quantitative indexes of beta-cell function during graded up and down glucose infusion from C-peptide minimal models. Am J Physiol Endocrinol Metab 280:E2–E10PubMed
Metadata
Title
Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery
Authors
S. Salinari
A. Bertuzzi
A. Iaconelli
M. Manco
G. Mingrone
Publication date
01-07-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 7/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1007-y

Other articles of this Issue 7/2008

Diabetologia 7/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.